Listar por autor "Lafuente J.V."
Mostrando ítems 1-20 de 28
-
Article
A neurocognitive approach for recovering upper extremity movement following subacute stroke: A randomized controlled pilot study (2020)
Sallés L.; Martín-Casas P.; Gironès X.; Durà M.J.; Lafuente J.V.; Perfetti C. (Society of Physical Therapy Science (Rigaku Ryoho Kagakugakkai), 2017) -
Article
A neurocognitive approach to recovery of movement following stroke (2020)
Sallés L.; Gironès X.; Martín-Casas P.; Lafuente J.V. (Taylor and Francis Ltd., 2015) -
Article
Association of Notch-1, osteopontin and stem-like cells in ENUglioma malignant process (2020)
Bulnes S.; Bermúdez G.; Lafuente J.V. (Impact Journals LLC, 2018) -
Review
Blood-brain barrier changes in high altitude (2020)
Lafuente J.V.; Bermudez G.; Camargo-Arce L.; Bulnes S. (Bentham Science Publishers B.V., 2016) -
Conference Paper
Co-administration of TiO2 nanowired cerebrolysin and alpha-melanocyte stimulating hormone has superior neuroprotective effects on brain pathology following concussive head injury after Sleep deprivation (2020)
Sharma A.; Muresanu D.F.; Lafuente J.V.; Nozari A.; Patnaik R.; Ozkizilcik A.; Tian Z.R.; Mössier H.; Sharma H.S. (TechConnect, 2018) -
Article
Co-administration of TiO2 nanowired mesenchymal stem cells with cerebrolysin potentiates neprilysin level and reduces brain pathology in alzheimer’s disease (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Patnaik R.; Tian Z.R.; Ozkizilcik A.; Castellani R.J.; Mössler H.; Sharma A. (Humana Press Inc., 2018) -
Article
Cold environment exacerbates brain pathology and oxidative stress following traumatic brain injuries: Potential therapeutic effects of nanowired antioxidant compound H-290/51 (2020)
Sharma A.; Muresanu D.F.; Lafuente J.V.; Sjöquist P.-O.; Patnaik R.; Tian Z.R.; Ozkizilcik A.; Sharma H.S. (Humana Press Inc., 2018) -
Erratum
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x) (2020)
Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; Bulnes S.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018) -
Article
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease (2020)
Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; Bulnes S.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018) -
Article
Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model (2020)
Murueta-Goyena A.; Morera-Herreras T.; Miguelez C.; Gutiérrez-Ceballos A.; Ugedo L.; Lafuente J.V.; Bengoetxea H. (Elsevier B.V., 2019) -
Article
Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway (2020)
Bengoetxea H.; Rico-Barrio I.; Ortuzar N.; Murueta-Goyena A.; Lafuente J.V. (Humana Press Inc., 2018) -
Article in Press
Erratum to: Short-Term Exposure to Enriched Environment in Adult Rats Restores MK-801-Induced Cognitive Deficits and GABAergic Interneuron Immunoreactivity Loss (2020)
Murueta-Goyena A.; Ortuzar N.; Gargiulo P.Á.; Lafuente J.V.; Bengoetxea H. (Humana Press Inc., 2017) -
Article
Histamine H3 inverse agonist BF 2649 or antagonist with partial h4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in alzheimer’s disease (2020)
Patnaik R.; Sharma A.; Skaper S.D.; Muresanu D.F.; Lafuente J.V.; Castellani R.J.; Nozari A.; Sharma H.S. (Humana Press Inc., 2018) -
Book Chapter
Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment (2020)
Menon P.K.; Sharma A.; Lafuente J.V.; Muresanu D.F.; Aguilar Z.P.; Wang Y.A.; Patnaik R.; Mössler H.; Sharma H.S. (Academic Press Inc., 2017) -
Article
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors (2020)
Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; García-Blanco A.; Herrán E.; Aristieta A.; Igartua M.; Pedraz J.L.; Ugedo L.; Hernández R.M.; ... (Humana Press Inc., 2017) -
Article
Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease (2020)
Requejo C.; Ruiz-Ortega J.A.; Cepeda H.; Sharma A.; Sharma H.S.; Ozkizilcik A.; Tian R.; Moessler H.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018) -
Conference Paper
Nanodelivery of cerebrolysin reduces depressive stress induced exacerbation of Alzheimer's disease brain pathology following amyloid-beta peptide infusion (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Patnaik R.; Tian Z.R.; Ozkizilcik A.; Castellani R.J.; Mossier H.; Sharma A. (TechConnect, 2017) -
Conference Paper
Nanodelivery of cerebrolysin reduces functionalized Gold Nanoparticles induced Blood-brain barrier disruption, brain edema formation and brain pathology (2020)
Sharma A.; Menon P.K.; Muresanu D.F.; Lafuente J.V.; Nozari A.; Patnaik R.; Ozkizilcik A.; Tian Z.R.; Mössler H.; Sharma H.S. (TechConnect, 2017) -
Article
Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51 (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Sjöquist P.-O.; Patnaik R.; Sharma A. (Humana Press Inc., 2015) -
Article
Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord (2020)
Muresanu D.F.; Sharma A.; Lafuente J.V.; Patnaik R.; Tian Z.R.; Nyberg F.; Sharma H.S. (Humana Press Inc., 2015)